{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:22:22Z","timestamp":1753521742247},"reference-count":0,"publisher":"IOS Press","isbn-type":[{"value":"9781643684529","type":"print"},{"value":"9781643684536","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,26]]},"abstract":"<jats:p>Existing research has focused on the positive impact of the Volume-Based Procurement Policy on Chinese healthcare and national life. However, the impact of this policy on the strategies of pharmaceutical firms has yet to be further explored. In this paper, with a sample of A-share listed pharmaceutical firms from 2012\u20132021, we analyze the impact of the Volume-Based Procurement Policy on firms\u2019 innovation investment. Through difference-in-differences analysis, we find that the policy significantly promotes pharmaceutical firms\u2019 innovation investment, and this result still holds after the placebo test and the test using propensity score matching method. In addition, we find that the incentive effect of the policy on innovation investment is stronger for non-state-owned firms and small-scale firms. This paper empirically tests the effects of the impact of the Volume-Based Procurement Policy on innovation and provides implications for the further implementation of the policy.<\/jats:p>","DOI":"10.3233\/faia230743","type":"book-chapter","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T08:23:32Z","timestamp":1698654212000},"source":"Crossref","is-referenced-by-count":2,"title":["The Impact of the Volume-Based Procurement Policy on Organizational Innovation Investment: Evidence from Chinese A-share Pharmaceutical Firms"],"prefix":"10.3233","author":[{"given":"Ruomin","family":"Huang","sequence":"first","affiliation":[{"name":"WeBank Institute of Fintech, Shenzhen University, Shenzhen, China"}]},{"given":"Yukun","family":"Feng","sequence":"additional","affiliation":[{"name":"WeBank Institute of Fintech, Shenzhen University, Shenzhen, China"},{"name":"Faculty of Business Administration, University of Macau, Macau, China"}]},{"given":"Yumin","family":"Cao","sequence":"additional","affiliation":[{"name":"Faculty of Business Administration, University of Macau, Macau, China"}]}],"member":"7437","container-title":["Frontiers in Artificial Intelligence and Applications","Digitalization and Management Innovation II"],"original-title":[],"link":[{"URL":"https:\/\/ebooks.iospress.nl\/pdf\/doi\/10.3233\/FAIA230743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T08:23:34Z","timestamp":1698654214000},"score":1,"resource":{"primary":{"URL":"https:\/\/ebooks.iospress.nl\/doi\/10.3233\/FAIA230743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"ISBN":["9781643684529","9781643684536"],"references-count":0,"URL":"https:\/\/doi.org\/10.3233\/faia230743","relation":{},"ISSN":["0922-6389","1879-8314"],"issn-type":[{"value":"0922-6389","type":"print"},{"value":"1879-8314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]}}}